Cefiderocol-Based versus Colistin-Based Regimens for Severe Carbapenem-Resistant <i>Acinetobacter baumannii</i> Infections: A Propensity Score-Weighted, Retrospective Cohort Study during the First Two Years of the COVID-19 Pandemic

Cefiderocol-Based versus Colistin-Based Regimens for Severe Carbapenem-Resistant <i>Acinetobacter baumannii</i> Infections: A Propensity Score-Weighted, Retrospective Cohort Study during the First Two Years of the COVID-19 Pandemic

Background. A large increase in multi-drug-resistant <i>Acinetobacter baumannii</i>, especially carbapenem-resistant strains, occurred during the first two years of the COVID-19 pandemic, posing important challenges in its treatment. Cefiderocol appeared to be a good option for the treat...

Full description

Bibliographic Details
Main Authors: Maria Mazzitelli, Dario Gregori, Lolita Sasset, Marco Trevenzoli, Vincenzo Scaglione, Sara Lo Menzo, Serena Marinello, Daniele Mengato, Francesca Venturini, Ivo Tiberio, Paolo Navalesi, Annamaria Cattelan
Format: Article
Language:English
Published: MDPI AG 2023-04-01
Series:Microorganisms
Subjects:
cefiderocol
colistin
<i>Acinetobacter baumannii</i>
CR-Ab
multi-drug resistant
pneumonia
Online Access:https://www.mdpi.com/2076-2607/11/4/984

Internet

https://www.mdpi.com/2076-2607/11/4/984

Similar Items